Talaromycesone A
Talaromycesone A is an oxaphenalenone dimer compound. Talaromycesone A exhibits potent antibacterial activities with an IC50 of 3.70 μM, against human pathogenic Staphylococcus strains. Talaromycesone A displays potent acetylcholinesterase inhibitory activities with an IC50 of 7.49 μM[1].
Product Specifications
CAS Number
[1658474-60-2]
UNSPSC
12352005
Target
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/talaromycesone-a.html
Solubility
10 mM in DMSO
Smiles
CC(O[C@@]1([C@]23[C@](C4)([H])[C@@](OC)(C5=C(C)C=C(O)C6=C5C4=C(OC6=O)O)[C@@]1([H])C(C7=C(C)C=C(O)C(C(OC3)=O)=C27)=O)[H])=O
Molecular Formula
C29H24O11
Molecular Weight
548.49
References & Citations
[1]Wu B, et al. Acetylcholinesterase inhibitors from a marine fungus Talaromyces sp. strain LF458. Mar Biotechnol (NY) . 2015;17 (1) :110-119.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
USP30, NT (USP30, Ubiquitin carboxyl-terminal hydrolase 30, Deubiquitinating enzyme 30, Ubiquitin thioesterase 30, Ubiquitin-specific-processing protease 30) (MaxLight 490) discontinued
Lentiviral human TMEM132E shRNA (UAS) - Lentiviral human TMEM132E shRNA (UAS) (100)
